AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06212219 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Reaching Performance Scale
Description: This scale analyzes the evolution of speed, precision and range of movement using motion capture tools. For each statement, the patient has a rating between 0 (corresponds to not possible) and 3 (corresponds to entirely possible)
Study NCT05261984 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Resistance exercise
Description: Knee extensions in flywheel inertia machine in four sets of 10 repetitions.
Study NCT05261984 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: Knee extensions in flywheel inertia machine in four sets of 10 repetitions.
Study NCT05261984 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral protein supplementation
Description: 24 grams of hydrolyzed whey protein.
Study NCT05261984 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral protein supplementation
Description: 24 grams of hydrolyzed whey protein.
Study NCT06303063 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SINOMED IAS Stent System
Description: Stent-assisted coiling (SAC) of intracranial aneurysms paved the way for endovascular coiling of wide-neck aneurysms, improving rates of aneurysm obliteration and recurrence.
Study NCT06303063 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuroform Atlas Stent System
Description: Stent-assisted coiling (SAC) of intracranial aneurysms paved the way for endovascular coiling of wide-neck aneurysms, improving rates of aneurysm obliteration and recurrence.
Study NCT05179772 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Olanzapine (2.5 mg to 20 mg)
Study NCT05067296 — intervention group
Intervention type: OTHER
Intervention: By TVS
Description: Uses of TVS to diagnosis of Cesarean section niche in patients with abnormal uterine bleeding
Study NCT05789901 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MARVIN
Description: Chatbot on Meta (Facebook) Messenger for HIV Patients
Study NCT05789901 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MARVIN-Pharma
Description: Chatbot on Meta (Facebook) Messenger for community pharmacists
Study NCT05789901 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MARVINA
Description: Chatbot on Meta (Facebook) Messenger for breast cancer patients
Study NCT06220578 — intervention group
Intervention type: DEVICE
Intervention: Oculus pentacam HR
Description: Examination of corneal parameters by pentacam
Study NCT04093388 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Self-PAP
Description: A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.
Study NCT04093388 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Traditional Pap smear
Description: A single cohort of 250 patients will be recruited from among those who need a Papanicolaou (Pap) smear for routine cervical cancer screening, to perform a self-administered Pap smear immediately prior to the traditional Pap smear. Blinded assessment of both tests will be then conducted.
Study NCT04988256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclosporine
Description: Patients randomized to cyclosporine will be treated as mentioned under Arm/Group Description
Study NCT04988256 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone and Prednisone
Description: All patients randomized to steroids will initially be treated with IV methylprednisolone and eventually started on an oral prednisone taper.
Study NCT04107272 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real repetitive transcranial magnetic stimulation
Description: The real rTMS will be delivered over M1 (hand representation) of dual hemispheres with 10 trains of 10 Hz pulses for 10 seconds, with a total of 1,000 pulses per hemisphere. The real rTMS intensity will be set as 80% resting motor threshold and the interval between each train of pulses will be set as 50 seconds. The real rTMS will be delivered as daily session for five consecutive days, followed by two fortnightly maintenance sessions during the follow-up period after the completion of five daily sessions. The real rTMS will be delivered by designated physical therapists using figure-of-8 shaped coil.
Study NCT04107272 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation
Description: The sham rTMS of this study will be delivered with the same active coil angled 90-degree way from the scalp. The intensity of sham rTMS will be set at lowest stimulator output that can generate similar noise to the real rTMS. The sham rTMS will be delivered in the same manner and duration with real rTMS.
Study NCT05999214 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 99mTc-H7ND SPECT/CT imaging performed
Description: 99mTc-H7ND SPECT/CT imaging positive (+) was defined as the presence of at least one measurable lesion and the uptake of the lesion was greater than that of normal liver in the experimental group, and patients were divided into SD+ and SD-. According to the guidelines and routine clinical practice, SD- patients were treated with the original regimen or maintenance treatment, and SD+ patients were divided into continuation of the original regimen or second-line treatment according to the MDT discussion results.
Study NCT06416514 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalized intervention
Description: Personalized intervention means implementing multi-component non-pharmacological interventions based on different health profiles，such as art therapy, exercise therapy, cognitive therapy and other monotherapies. Usual care means care as routine.
Study NCT05789901 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: MARVIN-CHAMP
Description: CHatbot to Assist the Management of Pediatric patients with infectious conditions (CHAMP)
Study NCT05171816 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: 300 mg (2 x 150 milligrams (mg) tablets) twice daily
Study NCT05171816 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: abiraterone acetate
Description: 1000 milligrams (mg) once daily
Study NCT05171816 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: abiraterone acetate
Description: 1000 milligrams (mg) once daily
Study NCT05049109 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated Telehealth After Stroke Care
Description: • 3 week and 8 week follow up visits with pharmacy through telehealth~Patients will provide home blood pressure monitoring kits at discharge for the first three months. The telemonitor that can send blood pressure readings, wirelessly or through telephone, to a secure server where study staff can look at the readings. Any blood pressure readings that are not within normal range will trigger an alert to be sent to study staff who will then follow up with the patient. A trained staff member will show the patient how to use the blood pressure monitor. Patients will be asked to take blood pressure at least 3 days per week and transmit the readings to study staff.~Patients will also be asked to wear an activity monitor starting at 4 weeks.
Study NCT05049109 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual post-stroke follow-up care
Description: * 1-2 weeks follow up visit with primary care.~* 4-6 week and 12 week follow up visit with stroke practitioner~* At the end of the study, patients will be asked questions regarding their experience with the telehealth visits, health, medication taking and quality of life
Study NCT05049109 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual post-stroke follow-up care
Description: * 1-2 weeks follow up visit with primary care.~* 4-6 week and 12 week follow up visit with stroke practitioner~* At the end of the study, patients will be asked questions regarding their experience with the telehealth visits, health, medication taking and quality of life
Study NCT04814056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib Dimaleate
Description: Afatinib is the second-generation TKI drug, which can irreversibly bind to receptors of erbB family. Afatinib will be administered orally at a dose of 40 mg per time, Q.D. If a patient cannot tolerate a dose of 40mg due to adverse reactions, when the adverse reactions restore to level 1 (CTCAE 5.0) or below, the dosage could be adjusted to 30mg per day, Q.D.
Study NCT06121024 — intervention group
Intervention type: PROCEDURE
Intervention: Interventional Bronchoscopy
Description: Bronchoscopy offers vital information when evaluating patients suffering from tracheal stenosis. It enables direct visualisation which identifies the lesion, determines its location and extent of airway involvement, highlights vascularity and fragility, allows for tissue diagnosis and enables the operator to assess the extent of mucosal infiltration and airway compression caused by the tumour. The technique facilitates assessment of stenosis diameter for suitable stent selection. In addition to enabling diagnostic bronchoscopy, rigid bronchoscopy offers therapeutic options such as dilatation, cryotherapy and stenting for tracheal stenosis patients. Our clinical setting employs rigid bronchoscopy for interventional procedures with both diagnostic and therapeutic aspects.
Study NCT04421248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Description: In ADHD participants only: blinded, randomized, placebo-controlled single dose, crossover on separate days separated by at least one week.
Study NCT04421248 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: In ADHD participants only: blinded, randomized, placebo-controlled, single dose, crossover on separate days separated by at least one week.
Study NCT05945173 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Evaporation time for 5 seconds
Description: Composite resin restorations of non-carious cervical lesions will be performed with an adhesive with solvent evaporation for 5 seconds.
Study NCT05945173 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Evaporation time for 25 seconds
Description: Composite resin restorations of non-carious cervical lesions will be performed with an adhesive with solvent evaporation for 25 seconds.
Study NCT05945173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: alcohol/water-based universal adhesive
Description: Composite resin restorations of non-carious cervical lesions will be performed with an alcohol/water-based universal adhesive (Scotchbond Universal Plus; 3M).
Study NCT06297707 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aquatic high intensity resistive training
Description: The experimental group participants will involve in aquatic high intensity resistive training sessions. The participants in the intervention group will receive 1 h of supervised lower limb aquatic resistance training three times a week for 12 weeks, for a total of 36 training sessions.
Study NCT06297707 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: usual care
Description: The control group will maintain usual care and will be asked to continue their usual leisure time activities. They will be offered the possibility of participating in two sessions consisting of 1 h of light stretching and relaxation during the 3-month intervention period.
Study NCT05164926 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: perineal massage with St. John's Wort oil
Description: perineal massage with St. John's Wort oil during labor
Study NCT05026203 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: Ketamine hydrochloride 0.5 mg/kg intravenous administer in 40 minutes per day for 3 consecutive days
Study NCT05026203 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Midazolam
Description: Midazolam
Study NCT05945173 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: alcohol/water-based universal adhesive
Description: Composite resin restorations of non-carious cervical lesions will be performed with an alcohol/water-based universal adhesive (Scotchbond Universal Plus; 3M).
Study NCT05945173 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: acetone-based universal adhesive
Description: Composite resin restorations of non-carious cervical lesions will be performed with an acetone-based universal adhesive (Gluma Universal Bond; Kulzer).
Study NCT05945173 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acetone-based universal adhesive
Description: Composite resin restorations of non-carious cervical lesions will be performed with an acetone-based universal adhesive (Gluma Universal Bond; Kulzer).
Study NCT05698966 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: we will use reduced dose of acceptable corticosteroids treatment for preterm birth
Description: the two different group will differ in the doses of corticosteroids
Study NCT05698966 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: we will use reduced dose of acceptable corticosteroids treatment for preterm birth
Description: the two different group will differ in the doses of corticosteroids
Study NCT05375734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab in combination with anlotinib
Description: Tislelizumab：200 mg，ivgtt，d1，Q3W anlotinib： 10mg P.O d1-d14, Q3W
Study NCT05372692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mesothelin-specific chimeric antigen receptor T cell injection
Description: Autologous T cell injection
Study NCT06329206 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GH2616 Tablets
Description: GH2616 tablets will be given orally
Study NCT05612425 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Behavior Fading for Appearance Concerns
Description: Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
Study NCT05612425 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unhealthy Behavior Fading
Description: Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.
Study NCT02346617 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IFN-γ positive selected T-cells
Description: No intervention
Study NCT05009290 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR3680
Description: Treatment group: SHR3680 240 mg orally once daily before or after breakfast, 28 days per cycle for a total of 12 treatment cycles (6 cycles before and 6 cycles following radical prostatectomy).~Goserelin acetate sustained-release depot: 10.8 mg administered subcutaneously into the anterior abdominal wall once every 3 cycles (12 weeks) for a total of 12 cycles.
Study NCT05009290 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Treatment group ：Placebo 240 mg orally once daily before or after breakfast, 28 days per cycle for a total of 12 treatment cycles (6 cycles before and 6 cycles following radical prostatectomy).~Goserelin acetate sustained-release depot: 10.8 mg administered subcutaneously into the anterior abdominal wall once every 3 cycles (12 weeks) for a total of 12 cycles.
Study NCT06031363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin Suppository
Description: Patients in the regular dose group are given indomethacin suppository 100 mg anal plug immediately after operation, patients in the low dose group are given indomethacin suppository 50 mg anal plug immediately after operation, and patients in the high dose group are given indomethacin suppository 150 mg anal plug immediately after operation.
Study NCT06031363 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Indomethacin Suppository
Description: Patients in the regular dose group are given indomethacin suppository 100 mg anal plug immediately after operation, patients in the low dose group are given indomethacin suppository 50 mg anal plug immediately after operation, and patients in the high dose group are given indomethacin suppository 150 mg anal plug immediately after operation.
Study NCT05400304 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: radiomics
Description: The high-throughput extraction of large amounts of quantitative image features from medical images
Study NCT05158725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Colonoscopy
Description: In this arm, subjects will undergo colonoscopy using a standard colonoscope
Study NCT05158725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Discovery aided colonoscopy
Description: the Discovery is a customized detection support software, developed utilizing AI deep learning technology to support endoscopic lesion detection in the colon. In this arm, a standard colonoscope is used with the Discovery.
Study NCT05158725 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Discovery and G-EYE
Description: The G-EYE® Endoscope is a standard colonoscope which is remanufactured by installing the G-EYE® balloon on the distal bending section of the colonoscope. in this arm, the G-EYE® Endoscope is used with the Discovery
Study NCT05017610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liothyronine
Description: Given PO
Study NCT05017610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lomustine
Description: Given PO
Study NCT05017610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methimazole
Description: Given PO
Study NCT06304090 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: routine rehabilitation treatment
Description: All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy, to promote the development of motor and cognitive function, as well as to improve intellectual development\[. Besides, swallowing function training was also provided, including direct training, indirect training, and compensatory training, as follows The mendelson maneuver: performed 5 days per week, twice per day, 5-10 minutes each time.~Cold stimulation of the pharynx: performed every day, twice per day, 3-5 minutes each time.~Passive head extension: to stretch the submental muscle for 2-3 seconds, with upward resistance applied to the lower cheek for no less than 5 times a day and no less than 5 minutes each time.~Direct feeding training: with powdered milk, once a day, 5 days a week.
Study NCT06304090 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: routine rehabilitation treatment
Description: All participants were given routine rehabilitation treatment by professional rehabilitation therapists, including exercise therapy, guided education, psychological therapy, acupuncture and massage therapy, to promote the development of motor and cognitive function, as well as to improve intellectual development\[. Besides, swallowing function training was also provided, including direct training, indirect training, and compensatory training, as follows The mendelson maneuver: performed 5 days per week, twice per day, 5-10 minutes each time.~Cold stimulation of the pharynx: performed every day, twice per day, 3-5 minutes each time.~Passive head extension: to stretch the submental muscle for 2-3 seconds, with upward resistance applied to the lower cheek for no less than 5 times a day and no less than 5 minutes each time.~Direct feeding training: with powdered milk, once a day, 5 days a week.
Study NCT06304090 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Stellate ganglion block
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06304090 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stellate ganglion block
Description: The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT06304090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: The patients were provided with Stellate ganglion block , using 0.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g). The percutaneous approach via the paratracheal route was used for Stellate ganglion block . The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.
Study NCT05080556 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Treatment in both arms will be administered intravenously (IV) every 21 days (q21D) and for a maximum of 6 cycles in Arm 1 and 12 cycles in Arm 2.
Study NCT06312319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Respiratory training
Description: Respiratory training using the EMST 150 device to increase inspiratory and expiratory muscle strength.